CC
ZBH icon

Carlson Capital’s Zimmer Biomet ZBH Stock Holding History

Carlson Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-154,318
Closed -$22.4M – 303
2019
Q4 		$22.4M Sell
154,318
-32,273
-17% -$4.45M 0.4% 84
2019
Q3 		$24.9M Sell
186,591
-193,880
-51% -$25M 0.45% 81
2019
Q2 		$43.5M Buy
380,471
+100,440
+36% +$11.8M 0.66% 34
2019
Q1 		$34.7M Buy
280,031
+182,902
+188% +$20.8M 0.62% 39
2018
Q4 		$9.78M Buy
97,129
+56,238
+138% +$6.32M 0.15% 189
2018
Q3 		$5.22M Buy
+40,891
New +$4.86M 0.06% 226
2017
Q3 		– Sell
-362,534
Closed -$45.2M – 273
2017
Q2 		$45.2M Buy
362,534
+174,894
+93% +$20.7M 0.65% 36
2017
Q1 		$22.2M Buy
+187,640
New +$21.3M 0.28% 111
2016
Q2 		– Sell
-150,125
Closed -$15.5M – 338
2016
Q1 		$15.5M Buy
150,125
+32,267
+27% +$3.12M 0.19% 154
2015
Q4 		$11.7M Sell
117,858
-1,490
-1% -$146K 0.13% 191
2015
Q3 		$10.9M Sell
119,348
-17,819
-13% -$1.79M 0.13% 200
2015
Q2 		$14.5M Buy
+137,167
New +$15.2M 0.16% 176
2015
Q1 		– Sell
-72,380
Closed -$7.97M – 377
2014
Q4 		$7.97M Sell
72,380
-58,348
-45% -$6.15M 0.08% 249
2014
Q3 		$12.8M Sell
130,728
-2,554
-2% -$251K 0.14% 209
2014
Q2 		$13.4M Sell
133,282
-314,011
-70% -$30.6M 0.15% 204
2014
Q1 		$41.1M Sell
447,293
-99,555
-18% -$9.18M 0.48% 68
2013
Q4 		$49.5M Buy
546,848
+76,148
+16% +$6.59M 0.56% 61
2013
Q3 		$37.5M Buy
470,700
+401,690
+582% +$31.6M 0.51% 54
2013
Q2 		$5.02M Buy
+69,010
New +$5.16M 0.06% 253

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Carlson Capital's ZBH Position: Q1 2020 in Review

Carlson Capital sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 154,318 shares — an estimated $22.4M sold.

Carlson Capital first reported a position in ZBH in Q2 2013 and held it in 19 quarters. The position peaked at $49.5M in Q4 2013. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

  • Carlson Capital reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
  • Carlson Capital sold 154,318 Zimmer Biomet shares in Q1 2020, an estimated $22.4M.
  • Carlson Capital first reported a position in Zimmer Biomet in Q2 2013 and held it in 19 quarters.
  • Carlson Capital's Zimmer Biomet position peaked at $49.5M in Q4 2013.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Carlson Capital's 13F filing for Q1 2020, filed 14 May 2020.